Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: possible acute cardiac death; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number NL-LRB-00521326. An 80-year-old male patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 20Apr2021 (Batch/Lot Number: Unknown) as single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included diltiazem; clopidogrel; hydrochlorothiazide, losartan potassium (COZAAR PLUS); hydroxychloroquine sulfate (PLAQUENIL S); simvastatine; quetiapine; pantoprazole, all taken for an unspecified indication, start and stop date were not reported. On 25Apr2021, the patient experienced possible acute cardiac death. The patient died on 25Apr2021. An autopsy was not performed. Reporter''s comments: Previous COVID-19 infection: No. Other diagnostic procedures: no. Past drug therapy : covid-19 vaccin pfizer injvlst with no adverse reaction. No follow-up attempts are possible, information on batch number cannot be obtained.; Reported Cause(s) of Death: possible acute cardiac death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166